115 related articles for article (PubMed ID: 1334222)
1. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii infection after heart transplantation].
Vetter H; Reichenspurner H; Uberfuhr P; Netz H; Reichart B
Med Klin (Munich); 1992 Oct; 87 Suppl 1():56-9. PubMed ID: 1334222
[TBL] [Abstract][Full Text] [Related]
2. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
Lauchart W
Med Klin (Munich); 1992 Oct; 87 Suppl 1():60-4. PubMed ID: 1334223
[No Abstract] [Full Text] [Related]
3. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.
Merigan TC; Renlund DG; Keay S; Bristow MR; Starnes V; O'Connell JB; Resta S; Dunn D; Gamberg P; Ratkovec RM
N Engl J Med; 1992 Apr; 326(18):1182-6. PubMed ID: 1313549
[TBL] [Abstract][Full Text] [Related]
5. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Pneumocystis carinii and cytomegalovirus pneumonia after autologous peripheral blood stem cell transplantation.
Chuu WM; Catlett JP; Perry DJ; Geddes LG; Levit PD; Levy CS; Buick MK; Malkovska V
Bone Marrow Transplant; 1999 May; 23(10):1087-9. PubMed ID: 10373078
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of cytomegalovirus infection following heart transplantation].
Laske A; Carrel T; Niederhäuser U; Bauer E; Pasic M; von Segesser LK; Gallino A; Turina M
Helv Chir Acta; 1992 Jan; 58(4):527-32. PubMed ID: 1316336
[TBL] [Abstract][Full Text] [Related]
8. Use of cytomegalovirus (CMV) hyperimmune globulin for prevention of CMV disease in CMV-seropositive lung transplant recipients.
Zamora MR; Fullerton DA; Campbell DN; Leone S; Diercks MJ; Fisher JH; Badesch DB; Grover FL
Transplant Proc; 1994 Oct; 26(5 Suppl 1):49-51. PubMed ID: 7940974
[TBL] [Abstract][Full Text] [Related]
9. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
Shah T; Lai WK; Mutimer D
Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
[TBL] [Abstract][Full Text] [Related]
10. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
Schuler U; Ehninger G
Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220
[No Abstract] [Full Text] [Related]
11. [Comparison of the effect of 2 therapy concepts in the treatment of Pneumocystis carinii pneumonia. Cotrimoxazole for 21 days versus sequential therapy with cotrimoxazole followed by pentamidine inhalation].
Helm EB; Staszewski S; Arasteh K; Jacobi V; Mulert R; Wegner R; Ottmann O; Brodt HR; L'age M; Stille W
Med Klin (Munich); 1990 Apr; 85 Suppl 2():264-7. PubMed ID: 2374529
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
13. [Pneumocystis carinii pneumonia: a life threatening complication after kidney transplantation].
Chlebowski H; Westhoff A; Bach D; Grabensee B
Med Klin (Munich); 1992 Oct; 87 Suppl 1():49-52. PubMed ID: 1461228
[TBL] [Abstract][Full Text] [Related]
14. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors and prevention of pneumocystis carinii pneumonia after bone marrow transplantation].
Link H; Vöhringer HF; Wingen F; Brägas B; Schwardt A; Ehninger G
Med Klin (Munich); 1992 Oct; 87 Suppl 1():39-42. PubMed ID: 1461227
[TBL] [Abstract][Full Text] [Related]
16. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
[TBL] [Abstract][Full Text] [Related]
17. [Pentamidine inhalation in prevention of pneumocystis carinii pneumonia in treatment of rejection with monoclonal antibody Orthoclone (OKT-3)].
Barenbrock M; Spieker C; Buchholz B; Zidek W; Rahn KH
Med Klin (Munich); 1992 Oct; 87 Suppl 1():53-5. PubMed ID: 1461229
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
Casillo R; Grimaldi M; Ragone E; Maiello C; Marra C; De Santo L; Amarelli C; Romano G; Della Corte A; Portella G; Tripodi MF; Fortunato R; Cotrufo M; Utili R
Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
[TBL] [Abstract][Full Text] [Related]
20. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M
Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
